Combination of NF-κB Inhibitor and Docetaxel Enhances Anti-tumor Activity in Anaplastic Thyroid Cancer Cell Xenograft in Vivo

Combination of NF-κB Inhibitor and Docetaxel Enhances Anti-tumor Activity in Anaplastic Thyroid Cancer Cell Xenograft in Vivo Tianjin Medical Journal . 2010, (8): 0 -0 .